• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Canada
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Double gloves for prevention of transmission of blood borne pathogens to patients: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Immune response to hepatitis B vaccination: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Medication reconciliation at discharge: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Day programming for post-traumatic stress disorder: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) AmniSure versus fern testing to assess the rupture of fetal membranes in pregnant women: a review of the comparative accuracy, cost-effectiveness, and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Procedure site bleeding complications following percutaneous coronary interventions or angioplasty: a review of clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Codeine and acetaminophen for pain relief: a review of the clinical efficacy and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care testing: a review of systematic reviews on testing accuracy and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Abuse and misuse potential of pregabalin: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Periostat for periodontal disease: a review of the clinical effectiveness, cost effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic smoking cessation interventions for patients with cardiovascular conditions: a review of the safety and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dental treatment to correct dental caries in patients undergoing surgery: a review of clinical evidence on safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Chlorhexidine gluconate (CHG) for suturing in the emergency room and perineal washing during vaginal deliveries: a review of safety, evidence-based guidelines and recommendations
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dental x-rays and cancer: a review of the evidence on safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Composite resin and amalgam dental filling materials: a review of safety, clinical effectiveness and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adult psychiatric inpatients: a review of clinical evidence and effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel, prasugrel and ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness, cost effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Negative pressure wound therapy for patients with diabetic foot ulcers and pressure ulcers: a review of the clinical effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Custom foot orthotics for adults with foot conditions: a review of the clinical and cost effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental care programs in long term care: a review of the clinical effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Hydroxocobalamin for cyanide poisoning in the pre-hospital setting: a review of the comparative clinical effectiveness and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Denosumab and zoledronic acid for patients with postmenopausal osteoporosis: a review of the clinical effectiveness, safety, cost effectiveness, and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis: a review of the comparative clinical efficacy, safety and cost effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Modafinil for sleep disorders and fatigue secondary to multiple sclerosis: a review of the clinical efficacy and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Electrocardiograms versus x-rays for guided placement of central venous catheter tips: a review of clinical and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Drug eluting stents in adults with acute coronary syndrome: a review of the clinical effectiveness, safety and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-alcohol hand sanitizers for non-healthcare personnel: a review of the clinical effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Adaptive servo ventilation versus continuous or bi-level positive airway pressure: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Electronic cigarettes: a review of the clinical evidence and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Therapy dogs and horses for mental health: a review of the clinical effectiveness
2012     Medical Advisory Secretariat (MAS) Chronic Obstructive Pulmonary Disease (COPD)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Drug eluting stents in adults with in-stent restenosis: a review of the clinical effectiveness, safety and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Lymphocyte transformation testing (LTT) or lymphocyte proliferation testing (LPT) for hip or knee arthroplasty: a review of clinical and cost-effectiveness, and evidence-based guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Evaluation of acellular dermal matrix for breast reconstruction: an update
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dual antiplatelet therapy and enoxaparin or unfractionated heparin for patients with ST-elevation myocardial infarction: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) A systematic review of intravitreal bevacizumab for the treatment of diabetic macular edema
2012     HTA Unit, University of Calgary A health technology assessment of transient elastography in liver disease
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis: clinical effectiveness and harms
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: a health technology assessment
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) New oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of cancer-related secondary lymphedema]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of stroke care services]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Home diagnosis of obstructive sleep apnea in children]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Rare disease management: experiences from abroad]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Vancomycin or metronidazole for treatment of clostridium difficile infection: clinical and economic analyses
2011     Institute for Clinical Evaluative Sciences (ICES) Health system use by frail Ontario seniors: an in-depth examination of four vulnerable cohorts
2011     Institute for Clinical Evaluative Sciences (ICES) Ontario stroke evaluation report 2011: improving system efficiency by implementing stroke best practices
2011     Institute for Clinical Evaluative Sciences (ICES) Registry of the Canadian stroke network - report on the 2008/09 Ontario stroke audit
2011     Institute for Clinical Evaluative Sciences (ICES) Site-specific rates of shock, therapy and death after ICD implantation in Ontario: report from the Ontario ICD database
2011     Institute for Clinical Evaluative Sciences (ICES) Uptake of the new fee code for Ontario's enhanced 18-month well baby visit: a preliminary evaluation
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative skin preparation solutions: a review of the evidence on safety
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) MAKO's RESTORIS implants and MAKOplasty procedure for early to mid-stage osteoarthritic knee disease: a review of the clinical and cost-effectiveness and safety
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Blood pressure monitoring chairs to identify hypertension: a review of the clinical effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-gamma release assays testing versus tuberculosis skin testing for tuberculosis: a review of the clinical effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care cholesterol testing for coronary heart disease: a review of the clinical effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Disposable gloves for use in healthcare settings: a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Mycophenolate mofetil tablets for uveitis: a review of the comparative clinical and cost-effectiveness
2011     Medical Advisory Secretariat (MAS) Emerging pharmacogenomic tests
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis: a review of the clinical evidence
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and assessment tools for patients with chronic disease in therapeutic exercise program: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Parenteral versus oral methotrexate for the treatment of rheumatoid arthritis: a review of the clinical evidence
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Central monitors for acutely-ill cardiac patients in a small, rural hospital setting: a review of clinical and cost-effectiveness
2011     Institute for Clinical Evaluative Sciences (ICES) Geographic access to primary care and hospital services for rural and northern communities: report to the Ontario Ministry of Health and Long-Term Care
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines for children, adolescents and adults with ADHD
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) MALDI-TOF mass spectrometry for bacterial species identification: a review of diagnostic accuracy and clinical and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2011     Medical Advisory Secretariat (MAS) Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis
2011     Medical Advisory Secretariat (MAS) Continuous glucose monitoring for patients with diabetes
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Indications for positron emission tomography (pet): a brief update]
2011     Institute of Health Economics (IHE) Fecal transplantation for the treatment of clostridium difficile-associated disease or ulcerative colitis
2011     Institute for Clinical Evaluative Sciences (ICES) Geographic access to primary care and hospital services for rural and northern communities: Report to the Ontario Ministry of Health and Long-Term Care.
2011     Institute for Clinical Evaluative Sciences (ICES) Economic evaluation of percutaneous coronary intervention in stable coronary artery disease: studies in utilities, costs and decision modelling
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines and recommendations for ADHD in children and adolescents
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Multidisciplinary treatment programs for patients with non-malignant pain: a review of the clinical evidence, cost-effectiveness, and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular thermal ablation technologies for treatment of varicose veins: a review of clinical effectiveness, safety, cost-effectiveness, and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination therapy for pulmonary arterial hypertension: a review of the clinical effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs: a review of the clinical effectiveness, safety, and cost effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-selective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness